Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

[1]  D. Selkoe,et al.  Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity , 2014, Biochemistry.

[2]  P. McLean,et al.  α-Synuclein Multimers Cluster Synaptic Vesicles and Attenuate Recycling , 2014, Current Biology.

[3]  T. Südhof,et al.  α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation , 2014, Proceedings of the National Academy of Sciences.

[4]  S. Scarlata,et al.  Defining the oligomerization state of γ-synuclein in solution and in cells. , 2014, Biochemistry.

[5]  D. Selkoe,et al.  A New Method for Quantitative Immunoblotting of Endogenous α-Synuclein , 2013, PloS one.

[6]  R. Edwards,et al.  The Function of α-Synuclein , 2013, Neuron.

[7]  J. Shah,et al.  Activation and control of p53 tetramerization in individual living cells , 2013, Proceedings of the National Academy of Sciences.

[8]  Christos Proukakis,et al.  α-Synuclein mutations cluster around a putative protein loop☆ , 2013, Neuroscience Letters.

[9]  Jiajie Diao,et al.  Properties of native brain α-synuclein , 2013, Nature.

[10]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[11]  Nikolaus R. McFarland,et al.  Direct detection of alpha synuclein oligomers in vivo , 2013, Acta neuropathologica communications.

[12]  Christos Proukakis,et al.  A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.

[13]  Thomas Gurry,et al.  The dynamic structure of α-synuclein multimers. , 2013, Journal of the American Chemical Society.

[14]  J. Hardy,et al.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.

[15]  D. Selkoe,et al.  In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells* , 2013, The Journal of Biological Chemistry.

[16]  S. Chandra,et al.  Monomeric Synucleins Generate Membrane Curvature* , 2012, The Journal of Biological Chemistry.

[17]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[18]  H. Viadiu,et al.  The tetramer of p53 in the absence of DNA forms a relaxed quaternary state. , 2012, Biochemistry.

[19]  Steven M. Johnson,et al.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. , 2012, Journal of molecular biology.

[20]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[21]  D. Veprintsev,et al.  Specific Recognition of p53 Tetramers by Peptides Derived from p53 Interacting Proteins , 2012, PloS one.

[22]  Bernard Schneider,et al.  α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.

[23]  Wei Wang,et al.  A soluble α-synuclein construct forms a dynamic tetramer , 2011, Proceedings of the National Academy of Sciences.

[24]  T. Kamitani,et al.  Improved Immunodetection of Endogenous α-Synuclein , 2011, PloS one.

[25]  Shobini Jayaraman,et al.  Impact of Self-association on Function of Apolipoprotein A-I* , 2011, The Journal of Biological Chemistry.

[26]  D. Selkoe,et al.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation , 2011, Nature.

[27]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[28]  C. Lengner,et al.  Reprogramming of Postnatal Neurons into Induced Pluripotent Stem Cells by Defined Factors , 2011, Stem cells.

[29]  K. Sakaguchi,et al.  Cancer-associated p53 Tetramerization Domain Mutants , 2010, The Journal of Biological Chemistry.

[30]  C. Blackstone,et al.  A Lethal de Novo Mutation in the Middle Domain of the Dynamin-related GTPase Drp1 Impairs Higher Order Assembly and Mitochondrial Division* , 2010, The Journal of Biological Chemistry.

[31]  K. Sakaguchi,et al.  Enhancement of transcriptional activity of mutant p53 tumor suppressor protein through stabilization of tetramer formation by calix[6]arene derivatives. , 2010, Bioorganic & medicinal chemistry letters.

[32]  E. Kremmer,et al.  Transmembrane Protein 147 (TMEM147) Is a Novel Component of the Nicalin-NOMO Protein Complex* , 2010, The Journal of Biological Chemistry.

[33]  Lei Zhang,et al.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. , 2010, Genome research.

[34]  R. Nussbaum,et al.  Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. , 2010, Human molecular genetics.

[35]  K. Sakaguchi,et al.  Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain , 2009, Cell cycle.

[36]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[37]  D. Berg,et al.  Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Bradley T. Hyman,et al.  Formation of Toxic Oligomeric α-Synuclein Species in Living Cells , 2008, PloS one.

[39]  L. R. Manning,et al.  Human embryonic, fetal, and adult hemoglobins have different subunit interface strengths. Correlation with lifespan in the red cell , 2007, Protein science : a publication of the Protein Society.

[40]  T. Kerppola,et al.  Visualization of molecular interactions by fluorescence complementation , 2006, Nature Reviews Molecular Cell Biology.

[41]  W. Xia,et al.  Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain , 2004, Molecular and Cellular Neuroscience.

[42]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[43]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[44]  Christian Haass,et al.  Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain , 2000, The Journal of Neuroscience.

[45]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[46]  A. Jonas,et al.  Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.

[47]  J. Engler,et al.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[49]  W. Mantulin,et al.  The role of apolipoprotein AI domains in lipid binding. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[51]  B. Hyman,et al.  Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System , 1996, Journal of neuropathology and experimental neurology.

[52]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[53]  P. Friedman,et al.  The p53 protein is an unusually shaped tetramer that binds directly to DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Jonas,et al.  Asymmetry of apolipoprotein A-I in solution as assessed from ultracentrifugal, viscometric, and fluorescence polarization studies. , 1979, Biochemistry.

[55]  Chang-Deng Hu,et al.  Bimolecular fluorescence complementation (BiFC) analysis of protein-protein interaction: how to calculate signal-to-noise ratio. , 2013, Methods in cell biology.

[56]  I. Ial,et al.  Nature Communications , 2010, Nature Cell Biology.

[57]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[58]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[59]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[60]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.